Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

FATE Fate Therapeutics Inc

3,90

-0,24 (-5,80%)

18 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Fate Therapeutics (NASDAQ:FATE)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Fate Therapeutics Charts.

Fate Therapeutics (NASDAQ:FATE)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Fate Therapeutics Charts.

News Fate Therapeutics Inc

Form 8-K - Current report
Donnerstag 9 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
Donnerstag 9 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 9 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program
Donnerstag 9 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2024 Financial Results and Operational Updates
Montag 6 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting
Freitag 3 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
Montag 22 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference
Mittwoch 3 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Dienstag 2 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
Dienstag 19 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Dienstag 5 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Fate Therapeutics Inc News-Artikel

Gabelli Merger Plus+

SG Issuer Sg Issuer Fx A...

F3 Uranium (QB)

Leo Holdings Corporation... (PK)

Cohen and Steers MLP Inc...

FTSE MIB Net Total Retur...

Vontobel Financial Produ...

Afdb Zc Feb53 Mxn

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen